Xuzhou, China

Fei Dou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nhwa Pharma. Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Dou. Retrieved from https://idiyas.com/inventor/fei-dou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fei Dou - Innovator in Pharmaceutical Chemistry

Introduction

Fei Dou is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Fei Dou holds a patent for a lactam compound derivative, which is detailed in his invention titled "Lactam compound derivative and application thereof." This innovative compound is designed for use in a medicinal composition aimed at preventing or treating schizophrenia. The lactam compound derivative features a specific structure as shown in Formula I, highlighting its unique properties and potential benefits in medical applications.

Career Highlights

Fei Dou is currently associated with Nhwa Pharma Corporation, where he applies his expertise in pharmaceutical research and development. His work focuses on creating effective medicinal compounds that can address various mental health conditions.

Collaborations

Fei Dou collaborates with esteemed colleagues, including Minquan Yu and Yinli Qiu, who contribute to the research and development efforts at Nhwa Pharma Corporation. Their combined expertise enhances the innovation process and leads to the advancement of new therapeutic solutions.

Conclusion

Fei Dou's contributions to pharmaceutical chemistry, particularly through his patented lactam compound derivative, demonstrate his commitment to advancing medical science. His work at Nhwa Pharma Corporation and collaborations with fellow researchers underscore the importance of innovation in developing effective treatments for mental health disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…